Literature DB >> 18413890

Onset of cardiac iron loading in pediatric patients with thalassemia major.

John C Wood1, Raffaella Origa, Annalisa Agus, Gildo Matta, Thomas D Coates, Renzo Galanello.   

Abstract

We reviewed cardiac T2* assessments from 77 thalassemia major patients between the ages of 2.5 and 18 years to study optimal timing of cardiac iron screening by magnetic resonance imaging. No patient under 9.5 years of age showed detectable cardiac iron in contrast to 36% of patients between the ages of 15-18 years old, corresponding to an odds-ratio of 1.28 (28%) per year. All patients with cardiac iron had received at least 35 grams of transfusional iron. Liver iron and ferritin failed to predict cardiac iron loading. Initiation of cardiac magnetic resonance imaging assessment should be determined according to age and transfusional burden rather than indices of iron overload. When appropriate chelation therapy has been administered since birth, cardiac magnetic resonance imaging can be postponed until 8 years of age when anesthesia is not required. Patients with suboptimal chelation, increased transfusional requirements, or who have initiated transfusions later in life should be tested sooner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18413890      PMCID: PMC2892933          DOI: 10.3324/haematol.12513

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  13 in total

1.  Hepatic iron concentration and total body iron stores in thalassemia major.

Authors:  E Angelucci; G M Brittenham; C E McLaren; M Ripalti; D Baronciani; C Giardini; M Galimberti; P Polchi; G Lucarelli
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

2.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

Authors:  L J Anderson; S Holden; B Davis; E Prescott; C C Charrier; N H Bunce; D N Firmin; B Wonke; J Porter; J M Walker; D J Pennell
Journal:  Eur Heart J       Date:  2001-12       Impact factor: 29.983

3.  Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease.

Authors:  John C Wood; J Michael Tyszka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

4.  Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool.

Authors:  Peter D Jensen; Finn T Jensen; Thorkil Christensen; Hans Eiskjaer; Ulrik Baandrup; Johan L Nielsen
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

5.  Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia.

Authors:  Athanassios Aessopos; Christina Fragodimitri; Fotios Karabatsos; Antonia Hatziliami; Jacqueline Yousef; Anastasios Giakoumis; Aikaterini Dokou; Efstathios D Gotsis; Vasilis Berdoukas; Markissia Karagiorga
Journal:  Haematologica       Date:  2007-01       Impact factor: 9.941

6.  Iron in the heart. Etiology and clinical significance.

Authors:  L M Buja; W C Roberts
Journal:  Am J Med       Date:  1971-08       Impact factor: 4.965

7.  MRI detects myocardial iron in the human heart.

Authors:  Nilesh R Ghugre; Cathleen M Enriquez; Ignacio Gonzalez; Marvin D Nelson; Thomas D Coates; John C Wood
Journal:  Magn Reson Med       Date:  2006-09       Impact factor: 4.668

8.  Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.

Authors:  G M Brittenham; P M Griffith; A W Nienhuis; C E McLaren; N S Young; E E Tucker; C J Allen; D E Farrell; J W Harris
Journal:  N Engl J Med       Date:  1994-09-01       Impact factor: 91.245

9.  Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major.

Authors:  P T Telfer; E Prestcott; S Holden; M Walker; A V Hoffbrand; B Wonke
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

10.  Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

Authors:  Caterina Borgna-Pignatti; Simone Rugolotto; Piero De Stefano; Huaqing Zhao; Maria Domenica Cappellini; Giovanni Carlo Del Vecchio; Maria Antonietta Romeo; Gian Luca Forni; Maria Rita Gamberini; Roberta Ghilardi; Antonio Piga; Avital Cnaan
Journal:  Haematologica       Date:  2004-10       Impact factor: 9.941

View more
  28 in total

1.  T2* cardiovascular magnetic resonance in the management of thalassemia patients in Oman.

Authors:  Shahina Daar; Anil V Pathare; Rajeev Jain; Shoaib Al Zadjali; Dudley J Pennell
Journal:  Haematologica       Date:  2008-11-10       Impact factor: 9.941

2.  Sex differences and steroid modulation of cardiac iron in a mouse model of iron overload.

Authors:  Casey Brewer; Maya Otto-Duessel; Ruth I Wood; John C Wood
Journal:  Transl Res       Date:  2013-09-07       Impact factor: 7.012

3.  An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders.

Authors:  Jelena Rascon; Lina Rageliene; Sigita Stankeviciene; Darius Palionis; Algirdas Edvardas Tamosiunas; Nomeda Valeviciene; Tadas Zvirblis
Journal:  Eur J Pediatr       Date:  2014-09       Impact factor: 3.183

4.  Early cardiac iron overload in children with transfusion-dependent anemias.

Authors:  Juliano Lara Fernandes; Antonio Fabron; Monica Verissimo
Journal:  Haematologica       Date:  2009-10-08       Impact factor: 9.941

Review 5.  Use of magnetic resonance imaging to monitor iron overload.

Authors:  John C Wood
Journal:  Hematol Oncol Clin North Am       Date:  2014-08       Impact factor: 3.722

6.  Evaluation of Iron Overload in the Heart and Liver Tissue by Magnetic Resonance Imaging and its Relation to Serum Ferritin and Hepcidin Concentrations in Patients with Thalassemia Syndromes.

Authors:  Volkan Karakus; Ayşegül Kurtoğlu; Dilek Ersil Soysal; Yelda Dere; Selen Bozkurt; Erdal Kurtoğlu
Journal:  Indian J Hematol Blood Transfus       Date:  2016-10-07       Impact factor: 0.900

7.  Cardiac T2* MRI assessment in patients with thalassaemia major and its effect on the preference of chelation therapy.

Authors:  Arzu Akcay; Zafer Salcioglu; Kazim Oztarhan; Deniz Tugcu; Gonul Aydogan; Nuray Aktay Ayaz; Helen Bornaun; Hulya Sayilan Sen; Ferhan Akici; Burhan Akdana
Journal:  Int J Hematol       Date:  2014-04-10       Impact factor: 2.490

8.  Predicting factors for liver iron overload at the first magnetic resonance in children with thalassaemia major.

Authors:  Maddalena Casale; Maria Marsella; Massimiliano Ammirabile; Anna Spasiano; Silvia Costantini; Patrizia Cinque; Paolo Ricchi; Aldo Filosa
Journal:  Blood Transfus       Date:  2018-06-26       Impact factor: 3.443

Review 9.  Cardiac iron across different transfusion-dependent diseases.

Authors:  John C Wood
Journal:  Blood Rev       Date:  2008-12       Impact factor: 8.250

Review 10.  Physiology and pathophysiology of iron in hemoglobin-associated diseases.

Authors:  Thomas D Coates
Journal:  Free Radic Biol Med       Date:  2014-04-12       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.